Jiangsu Cancer Institute & Hospital
Clinical trials sponsored by Jiangsu Cancer Institute & Hospital, explained in plain language.
-
Immunotherapy before standard treatment may boost survival in esophageal cancer
Disease control OngoingThis phase 3 trial tests whether adding immunotherapy (sintilimab) and chemotherapy before standard chemoradiotherapy helps people with inoperable esophageal cancer live longer and reduces the chance of the cancer coming back. About 242 adults aged 18-75 with stage 2-4 esophageal…
Phase: PHASE3 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Personalized nursing may ease recovery after colorectal cancer surgery
Symptom relief TerminatedThis study aimed to compare personalized nursing care (including counseling, temperature monitoring, and recovery guidance) with standard nursing for people having laparoscopic colorectal cancer surgery. The goal was to see if the personalized approach could reduce anxiety, preve…
Phase: NA • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC